347 related articles for article (PubMed ID: 12210843)
21. Developmental loss of NT-3 in vivo results in reduced levels of myelin-specific proteins, a reduced extent of myelination and increased apoptosis of Schwann cells.
Woolley AG; Tait KJ; Hurren BJ; Fisher L; Sheard PW; Duxson MJ
Glia; 2008 Feb; 56(3):306-17. PubMed ID: 18080292
[TBL] [Abstract][Full Text] [Related]
22. Spontaneously immortalized Schwann cells from adult Fischer rat as a valuable tool for exploring neuron-Schwann cell interactions.
Sango K; Yanagisawa H; Kawakami E; Takaku S; Ajiki K; Watabe K
J Neurosci Res; 2011 Jun; 89(6):898-908. PubMed ID: 21394758
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 upregulates the expression of PMP22 in cultured rat Schwann cells via a JAK2-dependent pathway.
Ito T; Ikeda K; Tomita K; Yokoyama S
Neurosci Lett; 2010 Mar; 472(2):104-8. PubMed ID: 20122990
[TBL] [Abstract][Full Text] [Related]
24. Myelin gene expression in immortalized Schwann cells: relationship to cell density and proliferation.
Sasagasako N; Toda K; Hollis M; Quarles RH
J Neurochem; 1996 Apr; 66(4):1432-9. PubMed ID: 8627295
[TBL] [Abstract][Full Text] [Related]
25. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemistry study of human vestibular nerve schwannoma differentiation.
Hung G; Colton J; Fisher L; Oppenheimer M; Faudoa R; Slattery W; Linthicum F
Glia; 2002 Jun; 38(4):363-70. PubMed ID: 12007148
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination.
Bosse F; Zoidl G; Wilms S; Gillen CP; Kuhn HG; Müller HW
J Neurosci Res; 1994 Mar; 37(4):529-37. PubMed ID: 8021974
[TBL] [Abstract][Full Text] [Related]
28. Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene.
Hai M; Bidichandani SI; Patel PI
J Neurosci Res; 2001 Sep; 65(6):508-19. PubMed ID: 11550219
[TBL] [Abstract][Full Text] [Related]
29. Characterization of PMP22 expression in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(2):113-8. PubMed ID: 15262428
[TBL] [Abstract][Full Text] [Related]
30. Role of axons in the regulation of P0 biosynthesis by Schwann cells.
Brunden KR; Windebank AJ; Poduslo JF
J Neurosci Res; 1990 Jun; 26(2):135-43. PubMed ID: 1694900
[TBL] [Abstract][Full Text] [Related]
31. Myelin protein expression in dissociated superior cervical ganglia and dorsal root ganglia cultures.
Brunden KR; Ding Y; Hennington BS
J Neurosci Res; 1992 Aug; 32(4):507-15. PubMed ID: 1527797
[TBL] [Abstract][Full Text] [Related]
32. Endogenous glucocorticoids improve myelination via Schwann cells after peripheral nerve injury: An in vivo study using a crush injury model.
Morisaki S; Nishi M; Fujiwara H; Oda R; Kawata M; Kubo T
Glia; 2010 Jun; 58(8):954-63. PubMed ID: 20169622
[TBL] [Abstract][Full Text] [Related]
33. Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination.
Owens GC; Bunge RP
Glia; 1990; 3(2):118-24. PubMed ID: 1692007
[TBL] [Abstract][Full Text] [Related]
34. Tellurium-induced neuropathy: a model for reversible reductions in myelin protein gene expression.
Toews AD; Lee SY; Popko B; Morell P
J Neurosci Res; 1990 Aug; 26(4):501-7. PubMed ID: 1700139
[TBL] [Abstract][Full Text] [Related]
35. Disruption of fast axonal transport in vivo leads to alterations in Schwann cell gene expression.
Wu W; Toma JG; Chan H; Smith R; Miller FD
Dev Biol; 1994 Jun; 163(2):423-39. PubMed ID: 7515362
[TBL] [Abstract][Full Text] [Related]
36. A new long term in vitro model of myelination.
Callizot N; Combes M; Steinschneider R; Poindron P
Exp Cell Res; 2011 Oct; 317(16):2374-83. PubMed ID: 21777582
[TBL] [Abstract][Full Text] [Related]
37. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
38. Expression of P0 glycoprotein in CNS glia: effects of overexpression in N20.1 cells.
Studzinski DM; Benjamins JA
Glia; 2005 Nov; 52(3):234-44. PubMed ID: 15968635
[TBL] [Abstract][Full Text] [Related]
39. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
Carenini S; Neuberg D; Schachner M; Suter U; Martini R
Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
[TBL] [Abstract][Full Text] [Related]
40. Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths.
Puckett C; Hudson L; Ono K; Friedrich V; Benecke J; Dubois-Dalcq M; Lazzarini RA
J Neurosci Res; 1987; 18(4):511-8. PubMed ID: 2449540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
